(394) Effects of Age, Body Mass Index (BMI) and Diabetic Status on Testosterone Levels, Testosterone Dosing and Safety in Hypogonadal Men Treated with an Oral Testosterone Undecanoate (JATENZO)
Honig S, Swerdloff R, Wang C, Rohowsky N, Newmark J, Seo B, Dudley R. (394) Effects of Age, Body Mass Index (BMI) and Diabetic Status on Testosterone Levels, Testosterone Dosing and Safety in Hypogonadal Men Treated with an Oral Testosterone Undecanoate (JATENZO). The Journal Of Sexual Medicine 2023, 20: qdad060.368. DOI: 10.1093/jsxmed/qdad060.368.Peer-Reviewed Original ResearchBody mass indexOral testosterone undecanoateNon-diabetic groupTestosterone replacement therapyDiabetes statusDiabetic statusFinal doseDiabetic groupHypogonadal menTestosterone undecanoateT levelsEugonadal rangeBMI groupsMass indexHigher body mass indexDose-titration trialFinal mean dosesKey efficacy variablesTotal T levelsTotal T valuesHigh BMI groupStandard clinical measuresPlasma T levelsOral TULiver transaminases